The use of milrinone in pretransplant assessment of patients with congestive heart failure and pulmonary hypertension

Journal of Heart and Lung Transplantation

Volumn 18, Issue 4, 1999, Pages 367-371

  Pamboukian, Salpy V ^a   Carere, Ronald G ^a   Webb, John G ^a   Cook, Richard C ^a   D'Yachkova, Yulia ^a   Abel, James G ^a   Ignaszewski, Andrew P ^a  

^a ST PAUL S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MILRINONE; PHOSPHODIESTERASE INHIBITOR; CARDIOTONIC AGENT; VASODILATOR AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; DISEASE ASSOCIATION; FEMALE; HEART OUTPUT; HEART TRANSPLANTATION; HUMAN; LUNG VASCULAR RESISTANCE; MALE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SURGICAL RISK; BLOOD PRESSURE; DRUG EFFECT; FOLLOW UP; LUNG; LUNG WEDGE PRESSURE; MIDDLE AGED; RETROSPECTIVE STUDY; RISK FACTOR; SAFETY; SURVIVAL RATE; TREATMENT OUTCOME; VASCULAR RESISTANCE; VASCULARIZATION;

ADULT; AGED; BLOOD PRESSURE; CARDIAC OUTPUT; CARDIOTONIC AGENTS; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HEART TRANSPLANTATION; HUMANS; HYPERTENSION, PULMONARY; LUNG; MALE; MIDDLE AGED; MILRINONE; PHOSPHODIESTERASE INHIBITORS; PULMONARY WEDGE PRESSURE; RETROSPECTIVE STUDIES; RISK FACTORS; SAFETY; SURVIVAL RATE; TREATMENT OUTCOME; VASCULAR RESISTANCE; VASODILATOR AGENTS;

EID: 0032588934     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(98)00070-9     Document Type: Article

References (16)

1. Costard-Jackle A, Hill I, Schroeder J, Fowler M. The influence of preoperative patient characteristics on early and late survival following cardiac transplantation. Circulation 1991;Suppl III:III329-37.
2. Murali S., Kormos R., Uretski B., et al. Preoperative pulmonary hemodynamics and early mortality after orthotopic cardiac transplantation the Pittsburgh experience . Am Heart J. 126:1993;896-904.
3. Kirklin J., Nafter D., McGiffin D., McVay R., Blackstone E., Karp R. Analysis of morbid events and risk factors for death after cardiac transplantation. J Am Coll Cardiol. 11:1988;917-924.
4. Addonizio L, Gersony W, Robbins R, et al. Elevated pulmonary vascular resistance and cardiac transplantation. Circulation 1987;76:V52-5.
5. Costard-Jackle A., Fowler M. Influence of preoperative pulmonary artery pressure on mortality after heart transplantation testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining high risk group . J Am Coll Cardiol. 19:1992;48-54.
6. 1 in the pre-transplantation evaluation of heart failure patients with significant pulmonary hypertension. J Heart Lung Transplant. 11:1992;716-723.
7. Loh E., Stamler J., Hare J., Loscalzo J., Colucci W. Cardiovascular effects of inhaled nitric oxide in patients with left ventricular dysfunction. Circulation. 90:1994;2780-2785.
8. Semigran M., Cockrill B., Kacmarek R. Hemodynamic effects of inhaled nitric oxide in heart failure. J Am Coll Cardiol. 24:1994;982-988.
9. Kieler-Jensen N., Rickstein S., Stenqvist O. Inhaled nitric oxide in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance. J Heart Lung Transplant. 13:(3):1994;366-375.
10. Givertz M., Hare J., Loh E., Gauthier D., Colucci W. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction a rapid test for reversibility of pulmonary hypertension . J Am Coll Cardiol. 28:1996;1775-1780.
11. Alousi A., Johnson D. Pharmacology of the bipyridines amrinone and milrinone . Circulation. 73:(suppl. III):1986;III10-III24.
12. LeJemetel T., Maskin C., Mancini D., Sinoway L., Feld H., Chadwick B. Systemic and regional hemodyanamic effects of captopril and milrinone administered alone and concomitantly in patients with heart failure. Circulation. 72:1985;364-369.
13. Ludmer P., Wright R., Arnold M., Ganz P., Braunwald E., Colucci W. Separation of the direct myocardial and vasodilator actions of milrinone administered by an intracoronary infusion technique. Circulation. 73:1986;130-137.
14. Monrad E., Baim D., Smith H., Lanque A. Milrinone, dobutamine and nitroprusside comparative effects on hemodynamics and myocardial energetics in patients with severe congestive heart failure . Circulation. 73:(suppl. III):1986;III168-III74.
15. Baim D., McDowell A., Cherniles J. Evaluation of a new bipyridine inotropic agent - milrinone - in patients with severe congestive heart failure. N Engl J Med. 309:1983;748-756.
16. Jaski B., Fifer M., Wright R., Braunwald E., Colucci W. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. J Clin Invest. 75:1985;643-649.